Exosomes: Biogenesis, targeting, characterization and their potential as "Plug & Play" vaccine platforms

Biotechnol J. 2022 Nov;17(11):e2100646. doi: 10.1002/biot.202100646. Epub 2022 Aug 5.

Abstract

Exosomes are typically characterized as spherical extracellular vesicles less than 150 nm in diameter that have been released into the extracellular environment via fusion of multivesicular bodies (MVBs) to the plasma membrane. Exosomes play a key role in cell-cell communication, vary widely in their composition and potential cargo, and are reportedly involved in processes as diverse as angiogenesis, apoptosis, antigen presentation, inflammation, receptor-mediated endocytosis, cell proliferation, and differentiation, and cell-signaling. Exosomes can also act as biomarkers of health and disease and have enormous potential use as therapeutic agents. Despite this, the understanding of how exosome biogenesis can be utilized to generate exosomes carrying specific targets for particular therapeutic uses, their manufacture, detailed analytical characterization, and methods of application are yet to be fully harnessed. In this review, the author describes the current understanding of these areas of exosome biology from a biotechnology and bioprocessing aspect, but also highlight the challenges that remain to be overcome to fully harness the power of exosomes as therapeutic agents, with a particular focus on their use and application as vaccine platforms.

Keywords: biogenesis; bioprocessing; exosomes; extracellular vesicles; surface display; vaccine platform.

Publication types

  • Review

MeSH terms

  • Biological Transport
  • Cell Membrane / metabolism
  • Exosomes* / metabolism
  • Extracellular Vesicles* / metabolism
  • Vaccines*

Substances

  • Vaccines